{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T10:55:30Z","timestamp":1753181730228},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:00:00Z","timestamp":1553731200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s12098-019-02923-6","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T07:02:50Z","timestamp":1553756570000},"page":"714-716","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacokinetics of Second-Line Anti-Tubercular Drugs"],"prefix":"10.1007","volume":"86","author":[{"given":"Geetha","family":"Ramachandran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,28]]},"reference":[{"key":"2923_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s40265-014-0222-8","volume":"74","author":"A Abdullah","year":"2014","unstructured":"Abdullah A, Peloquin CA. Therapeutic drug monitoring in the treatment of tuberculosis: an update. Drugs. 2014;74:839\u201354.","journal-title":"Drugs"},{"key":"2923_CR2","doi-asserted-by":"publisher","unstructured":"Denti P, Garcia-Prats AJ, Draper HR, et al. Levofloxacin population pharmacokinetics in south African children treated for multidrug-resistance tuberculosis. Antimicrob Agents Chemother. 2017. \n                    https:\/\/doi.org\/10.1128\/AAC.01521-17\n                    \n                  .","DOI":"10.1128\/AAC.01521-17"},{"key":"2923_CR3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/cid\/ciu868","volume":"60","author":"S Thee","year":"2015","unstructured":"Thee S, Garcia-Prats AJ, Draper HR, et al. Pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosis. Clin Infect Dis. 2015;60:549\u201356.","journal-title":"Clin Infect Dis"},{"key":"2923_CR4","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.1128\/AAC.02755-13","volume":"58","author":"S Thee","year":"2014","unstructured":"Thee S, Garcia-Prats AJ, Mclleron HM, et al. Pharmacokinetics of ofloxacin and levofloxacin for prevention and treatment of multidrug-resistant tuberculosis in children. Antimicrob Agents Chemother. 2014;58:2948\u201351.","journal-title":"Antimicrob Agents Chemother"},{"key":"2923_CR5","doi-asserted-by":"crossref","unstructured":"Hemanth Kumar AK, Kumar A, Kannan T, et al. Pharmacokinetics of second-line anti-tuberculosis drugs in children with multidrug-resistant tuberculosis in India. Antimicrob Agents Chemother. 2018;62:e2410\u20137.","DOI":"10.1128\/AAC.02410-17"},{"key":"2923_CR6","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1128\/AAC.49.3.1106-1112.2005","volume":"49","author":"EV Capparelli","year":"2005","unstructured":"Capparelli EV, Reed MD, Bradley JS, et al. Pharmacokinetics of gatifloxacin in infants and children. Antimicrob Agents Chemother. 2005;49:1106\u201312.","journal-title":"Antimicrob Agents Chemother"},{"key":"2923_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/0091270004271944","volume":"45","author":"S Chien","year":"2005","unstructured":"Chien S, Wells TG, Blumber JL, et al. Levofloxacin pharmacokinetics in children. J Clin Pharmacol. 2005;45:153\u201360.","journal-title":"J Clin Pharmacol"},{"key":"2923_CR8","doi-asserted-by":"crossref","unstructured":"Mase SR, Jereb JA, Gonzalez D, et al. Pharmacokinetics and dosing of levofloxacin in children treated for active or latent multidrug-resistant tuberculosis Federated States of Micronesia and Republic of the Marshall Islands. Pediatr Infect Dis J. 2016;35:414\u201321.","DOI":"10.1097\/INF.0000000000001022"},{"key":"2923_CR9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/cpt.202","volume":"98","author":"RM Savic","year":"2015","unstructured":"Savic RM, Ruslami R, Hibma JE, et al. Pediatric tuberculosis meningitis: model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for children. Clin Pharmacol Ther. 2015;98:622\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"2923_CR10","doi-asserted-by":"publisher","first-page":"6073","DOI":"10.1128\/AAC.01404-15","volume":"59","author":"AJ Garcia-Prats","year":"2015","unstructured":"Garcia-Prats AJ, Draper HR, Thee S, et al. Pharmacokinetics and safety of ofloxacin in children in children with drug-resistant tuberculosis. Antimicrob Agents Chemother. 2015;59:6073\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"2923_CR11","unstructured":"Hesseling AC. 43rd World Union Conference on TB and lung health, 2012. Available at: \n                    https:\/\/www.theunion.org\/what-we-do\/journals\/ijtld\/...\/abstract_book_2012_web.pdf\n                    \n                  . Accessed 10th July 2018."},{"key":"2923_CR12","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1128\/AAC.00379-11","volume":"55","author":"S Thee","year":"2011","unstructured":"Thee S, Seifart HI, Rosenkranz B, et al. Pharmacokinetics of ethinomaide in children. Antimicrob Agents Chemother. 2011;55:4594\u2013600.","journal-title":"Antimicrob Agents Chemother"},{"key":"2923_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1054\/tube.2002.0330","volume":"82","author":"M Zhu","year":"2002","unstructured":"Zhu M, Namdar R, Stambaugh JJ, et al. Population pharmacokinetics of ethionamide in patients with tuberculosis. Tuberculosis (Edinb). 2002;82:91\u20136.","journal-title":"Tuberculosis (Edinb)"},{"key":"2923_CR14","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1345\/aph.19008","volume":"33","author":"JP DeVincenzo","year":"1999","unstructured":"DeVincenzo JP, Berning SE, Peloquin CA, Husson RN. Multidrug-resistant tuberculosis meningitis: clinical problems and concentrations of second-line antituberculosis medications. Ann Pharmacother. 1999;33:1184\u20138.","journal-title":"Ann Pharmacother"},{"key":"2923_CR15","first-page":"471","volume":"7","author":"L Soderhjelm","year":"1949","unstructured":"Soderhjelm L. Serum para-aminosalicylic acid following oral ingestion in children. Tex Rep Biol Med. 1949;7:471\u20139.","journal-title":"Tex Rep Biol Med"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-019-02923-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12098-019-02923-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-019-02923-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:30:02Z","timestamp":1585269002000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12098-019-02923-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,28]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["2923"],"URL":"https:\/\/doi.org\/10.1007\/s12098-019-02923-6","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,28]]},"assertion":[{"value":"25 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}